Grant: Pro. Gr.- PA: Human Development Child and Youth Health - Early Career Support
Université Laval
$100,000.00
Early prediction and clinical impact of venous thrombo-embolism in children with cancer
EF 2024-25
Résumé
Blood clots are a known complication of cancer and its treatment, and may lead to serious short- and long-term complications including death. In children, blood clots are often linked to a central venous line, a device inserted in the body to deliver medicine, fluids, or nutrients. While effective options exist to prevent blood clots, they are associated with side effects, costs, and increased burden on patients. No test or algorithm is currently available to help healthcare professionals identify which children are more likely to develop blood clots. Children at high risk of blood clots could benefit from medicine to treat adequately blood clots and minimize their impact.
We will perform a study enrolling children newly diagnosed with cancer (solid cancer outside the central nervous system) requiring chemotherapy or radiotherapy and a central venous line. Bloodwork will be performed on 4 occasions to identify blood tests, called biomarkers, that could predict blood clots. We will review health records and perform painless tests called Doppler ultrasounds to detect blood clots in participants.
We will follow the children for one year to determine whether they develop blood clots and complications of blood clots including catheter-related complications, post-thrombotic syndrome, and occlusion of blood vessels. A risk-assessment model taking into account clinical variables and laboratory results will be created to allow early identification of children at high risk of blood clots.
As survival from childhood cancer has increased drastically in the past decades, it is increasingly important to prevent complications such as blood clots and late effects of treatment.
Programme
Pro. Gr.- PA: Human Development Child and Youth Health - Early Career Support
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
514745
Name
Pelland-Marcotte Marie-Claude
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Clinical
Prcname2
Clinical Investigation - A: Reproduction, Maternal, Child and Youth Health
Projecttitle
Early prediction and clinical impact of venous thrombo-embolism in children with cancer
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Pro. Gr.- PA: Human Development Child and Youth Health - Early Career Support
Keyworddelim
Biomarkers; Central Venous Catheters; Children; Thrombosis
Abstract
Blood clots are a known complication of cancer and its treatment, and may lead to serious short- and long-term complications including death. In children, blood clots are often linked to a central venous line, a device inserted in the body to deliver medicine, fluids, or nutrients. While effective options exist to prevent blood clots, they are associated with side effects, costs, and increased burden on patients. No test or algorithm is currently available to help healthcare professionals identify which children are more likely to develop blood clots. Children at high risk of blood clots could benefit from medicine to treat adequately blood clots and minimize their impact.
We will perform a study enrolling children newly diagnosed with cancer (solid cancer outside the central nervous system) requiring chemotherapy or radiotherapy and a central venous line. Bloodwork will be performed on 4 occasions to identify blood tests, called biomarkers, that could predict blood clots. We will review health records and perform painless tests called Doppler ultrasounds to detect blood clots in participants.
We will follow the children for one year to determine whether they develop blood clots and complications of blood clots including catheter-related complications, post-thrombotic syndrome, and occlusion of blood vessels. A risk-assessment model taking into account clinical variables and laboratory results will be created to allow early identification of children at high risk of blood clots.
As survival from childhood cancer has increased drastically in the past decades, it is increasingly important to prevent complications such as blood clots and late effects of treatment.
Competitiondate
202409
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pelland-Marcotte, Marie-Claude
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~